Of 371 US patents citing UK neuroscience papers, 13.1 per cent of the inventors named are from the UK but only 3.4 per cent of the owners are UK-based companies and individuals. Wellcome said: "There appears to be an exploitation gap in this field, a generic problem of UK research."